 |
Kite Pharma
Last updated: April 19, 2024
Arie Belldegrun, founder
Country: USA | Funding: $335.4M (+)
Website: https://www.kitepharma.com/
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications. Acquired by Gilead Sciences
Website: https://www.kitepharma.com/
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications. Acquired by Gilead Sciences
